Compare HCA Health Inc (HCA) vs Jumia Technologies AG - ADR (JMIA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
HCA Health Inc vs Jumia Technologies AG - ADR — how do they compare? HCA Health Inc trades at $446.49 (market cap $96.35B), while Jumia Technologies AG - ADR trades at $6.45 (market cap $865.90M). The key difference: HCA Health Inc is far larger — about 111.3× Jumia Technologies AG - ADR's market cap, and HCA Health Inc pays a 0.7% dividend while Jumia Technologies AG - ADR pays none. Which is the better fit depends on your goals — on Pluang, investors hold HCA Health Inc for 76 Days and Jumia Technologies AG - ADR for 28 Days on average.
| HCA | JMIA | |
|---|---|---|
Market Cap | $96.35B | $865.90M |
Volume | 1,079,453 | 1,695,227 |
Sector | Health | Consumer Cyclical |
52-Week High | $545.13 | $14.60 |
52-Week Low | $361.32 | $5.69 |
Typical Hold Time | 76 Days | 28 Days |
Enterprise Value | $146.88B | $831.54M |
Dividend Yield | 0.7% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
HCA Healthcare (HCA) trades at $439.17, up 1.61% today, with a bullish technical signal and strong fundamental performance. Revenue grew to $75.6 billion in 2025, with net income reaching $6.78 billion, and the company has beaten EPS estimates for three consecutive quarters. Recent news includes an upcoming Q3 2026 earnings call and the completion of the College of Health Care Professions acquisition, highlighting operational expansion.
The outlook remains positive with a consensus price target of $461.12, though risks include ongoing legal investigations and high debt levels. Earnings growth and cost controls support upside potential, but investors should monitor regulatory developments and payer-mix pressures that could impact margins.
JMIA trades at $6.74, down 0.88% with a bearish technical signal despite analyst optimism. The company shows improving fundamentals with revenue growth to $189M in 2025 and narrowing losses, though it remains unprofitable with negative margins. Recent $50M capital injection and operational improvements support the path toward EBITDA breakeven by year-end 2026.
Investment outlook balances analyst bullishness (71% buy ratings, $12 consensus target) against persistent profitability challenges. Key opportunities include African e-commerce growth and cost optimization, while risks center on execution timeline and competitive pressures. The stock offers speculative upside if turnaround milestones are met.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About HCA Health Inc
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the U.S. As of December 2021, the firm owned and operated 182 hospitals, 125 freestanding outpatient surgery centers, and a broad network of physician offices, urgent care clinics, and freestanding emergency rooms across nearly 20 states and a small foothold in England.
Read more on HCA →About Jumia Technologies AG - ADR
Jumia Technologies AG is the pan-African e-commerce platform. The company's platform consists of a marketplace, which connects sellers with consumers. Its logistics service enables the shipment and delivery of packages from sellers to consumers, and the company's payment service facilitates transactions among participants active on its platform in selected markets. Jumia generates revenue from Sales of goods, Commissions, Fulfillment, Value-added services, and Marketing & Advertising. Its geographical segments are West Africa, North Africa, East & South Africa, Europe, and United Arab Emirates. The firm generates most of its revenue from the West Africa segment.
Read more on JMIA →
